BY no means an expert and as always, happy to be wrong........
A non inferior study generally takes a smaller sample that others.
Apparently it takes a smaller sample size to demonstrate that a product is similar (or no worse) than to prove it is different (better than).
Essentially, the sample size for the trial may be smaller ( and achieved sooner) than some us have been suggesting......
Hopefully the study protocol will be released soon......
Clinical trials, page-20
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.30 |
Change
0.300(2.31%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.40 | $13.20 | $204.6K | 15.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 454 | $13.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.49 | 110 | 1 |
View Market Depth
| Last trade - 10.55am 12/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |